GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...

The Commercial Observer Breakthrough Awards showed how the commercial real estate industry has risen above its challenges to ...

OpenAI’s efforts to develop its next major model, GPT-5, are running behind schedule, with results that don’t yet justify the ...

The startup has run into problem after problem on its new artificial-intelligence project, code-named Orion.

Patronus AI launches Glider, a breakthrough 3.8B-parameter language model that rivals GPT-4's evaluation capabilities while running on-device, offering transparent AI assessment with detailed ...

Pfizer's trailing-12-month (TTM) revenue is $59.3 billion, whereas its TTM normalized diluted earnings per share (EPS) is ...

Pfizer on Tuesday said it does not expect the Trump administration to make major changes to vaccine policy next year even as ...

Issues with data quality, competing projects, and high-profile executive exits are allegedly all contributing to the slowdown ...

Pfizer shares rose Tuesday morning after the pharmaceutical company affirmed its full-year 2024 projections and issued 2025 ...

The company forecast revenue next year will grow slightly versus this year, when excluding certain factors. “The uncertainty caused by COVID [is] mostly resolved,” its CFO said.

After pulling off a surprise third-quarter beat and full-year guidance raise amid shareholder activism earlier this year, Pfizer now expects its 2025 revenues to come in the same range as in 2024.